Aurobindo, Hetero, and Vivimed Class Action Settlements in Louisiana

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Louisiana residents.

Louisiana residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Louisiana residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Louisiana

Louisiana residents affected by contaminated blood pressure medications from manufacturers Aurobindo, Hetero, and Vivimed may be eligible for compensation through the $15.2 million Valsartan, Losartan and Irbesartan class action settlement. Louisiana's Unfair Trade Practices Act provides additional consumer protections beyond federal regulations, potentially strengthening claims against pharmaceutical companies that failed to disclose NDMA contamination in generic medications. These three manufacturers have significant distribution networks throughout Louisiana, with their generic medications widely dispensed through major pharmacy chains including CVS, Walgreens, and independent pharmacies serving rural communities across the state. Louisiana residents filing class action claims must be aware that the state follows a one-year prescription period for personal injury claims, though discovery rules may extend this timeline. The contamination affected millions of patients nationwide who took these commonly prescribed heart medications between 2012-2018. Louisiana's centralized court system in Baton Rouge handles many pharmaceutical class actions, and residents can typically join federal multidistrict litigation without needing separate Louisiana counsel.

How does Louisiana's prescription period affect my Aurobindo, Hetero, and Vivimed contamination claim?

Louisiana's one-year prescription period for personal injury claims typically begins when you discover the contamination, not when you first took the medication. Since NDMA contamination in Aurobindo, Hetero, and Vivimed medications wasn't widely publicized until 2018, many Louisiana residents may still have valid claims even if they took the medications years earlier.

Are Louisiana residents automatically included in the $15.2M Valsartan, Losartan and Irbesartan settlement?

Louisiana residents who took contaminated medications from Aurobindo, Hetero, and Vivimed must typically submit claim forms to participate in the settlement. The settlement covers patients nationwide, but you must provide documentation showing you purchased and consumed the affected medications during the specified time period.

Can I file a separate lawsuit in Louisiana state court against these manufacturers?

Most individual claims against Aurobindo, Hetero, and Vivimed have been consolidated into federal multidistrict litigation. However, Louisiana residents may have additional claims under state consumer protection laws that could be pursued separately, particularly if you suffered specific medical complications from the contaminated medications.

Tips for Louisiana Residents Filing Aurobindo, Hetero, and Vivimed Claims

Louisiana residents filing Aurobindo, Hetero, and Vivimed contamination claims should gather pharmacy records showing purchases of Valsartan, Losartan, or Irbesartan between 2012-2018. Contact your pharmacy to obtain detailed records showing manufacturer names and lot numbers. Keep medical records documenting any health issues potentially related to NDMA exposure. File settlement claims promptly as deadlines are strictly enforced. Consider consulting Louisiana attorneys familiar with pharmaceutical litigation, as state consumer protection laws may provide additional remedies beyond federal class action settlements. Document all out-of-pocket medical expenses and medication costs for potential reimbursement.

More Louisiana Resources